TSE:MFC

Manulife Financial (MFC.TO)

60.69
+0.02 (0.03%)
as of Jul 23, 2026, 8:00:00 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed perspectives from various analysts, reflecting both its potential and current market position. While many experts acknowledge MFC's solid dividend yield and growth prospects, particularly in Asia, concerns about valuation and market conditions persist. The stock appears to be trading around 2x book value and has shown slow but steady growth, attracting attention from those looking for income rather than explosive growth. The consensus among experts is to proceed with caution and consider market pullbacks for optimal entry points, though some view the stock as a good long-term hold due to its stable dividend and cash flow. Overall, while there are positive signs, such as asset management improvements and capital growth, analysts advise careful monitoring given the mixed signals surrounding the broader financial sector's performance.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
DON'T BUY
His least favourite in the lifecos. Operationally has been the best in North America with great growth potential in the far east. Got hung up with segregated funds in Canada and variable annuities in the US. Doesn't think they are even at half yet of hedging their portfolio. Will take a long time for investor confidence to come back.
TOP PICK
Did their last security issue to build a better financial picture for themselves. Doesn't think it's going up over the next 6 months but likes it for the long term. Price to Book is only about 1.3 times. Have growth in the US through John Hancock and in Asia.
DON'T BUY
Has Asian exposure, which he loves. However still in the penalty box for cutting dividends. Until they get out of this, there is no real rush to get into it.
DON'T BUY
Spent the last year trying to put its capital base back in “fortress” category. A couple of things are holding the company back. 1) It is most exposed of all the insurance companies to equity markets. 2) Pending changes to some of the capital requirements could put a crimp in the seg fund business.
COMMENT
7.68% Bonds maturing 2019? If you are a trader you’ve probably made the lion’s share of your capital gain and you could think about exiting in the next 3 to 6 months. If you hold on until maturity, 7.68% is a very nice yield.
DON'T BUY
Prefers Sun Life (SLF-T), which yields about 4.5%. Had some issues last year. Almost became a 2X proxy on the market because of their leveraged ETF. Since then have raised equity twice and cut the dividend. Expects Canadian insurance industry can do quite well.
BUY
Have lots of capital. There will be some volatility for the next little while. Great franchise in Canada and US and a growing franchise in Asia. Likes the prospects in 3 to 5 years from now.
BUY
(Market Call Minute.) Keep having bad news and it keeps getting in the penalty box but he thinks that things are going to come this year.
PAST TOP PICK
(A Top Pick Apr 8/09. Up 25.41%.) Still a buy.
BUY
Likes this company. Valuations looks more compelling than the banks. Good long-term hold.
TOP PICK
A contrarian pick because so many people where so badly hurt when dividend was cut and then by a share issue. On of the largest life insurance companies in the world. Thinks reserves will turn out to be too high and dividend will rise.
BUY ON WEAKNESS
Thinks we have seen the worst of the slide in the insurance sector. Maybe a little too expensive at this point.
BUY
Can see $30 in 2-3 years. Have a lot of growth in Asia. As credit concerns ease and equity markets go sideways to slightly higher their credit and capital will get better increasing their multiple.
DON'T BUY
This one is very tricky. Has been a big disappointment. Will probably stall out at around $22 and probably slide there for a while.
BUY
Now getting their house in order but there is still a degree of scepticism based on what would happen to capital requirements in another market meltdown. If you are looking out 2 to 3 years, it is a Buy.
Showing 1,501 to 1,515 of 2,283 entries